type 2 diabetes mellitus
Conditions
Interventions
On top of usual care, intervention patients participate in the tailored PTWD
diabetes self-management program, including trainer-led group meetings for a
period of 1.5 years. T2D patients in the con
Sponsors
Amsterdam UMC locatie AMC
Eligibility
Age
18 Years to 64 Years
Inclusion criteria
Inclusion criteria: being diagnosed with type 2 diabetes mellitus (T2D) since at least 1 year, aged > 35 and
Exclusion criteria
Exclusion criteria: - objection against participation from the general practitioner - a psychiatric disorder which hampers participation in the self-management program - being unable to come to the intervention location independently - planning to stay abroad for a longer time during the intervention period
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Secondary study outcomes include: - prescribed T2D medication and use of primary and secondary care - blood pressure and anthropometrics - diabetes-related distress, depression and quality of life - diabetes-related coping behaviors, other health-related behaviors | — |
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint of the DISC-2 study is a 5% decrease in HbA1c in the intervention group against no decrease in HbA1c in the control group, measured at 12 months after intervention patients started in the PTWD program. | — |
Countries
Netherlands
Outcome results
None listed